Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccinationArticle Published on 2022-11-012022-11-15 Journal: European journal of haematology [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome Adults antibody Antibody Response approved BNT162b2 Cell clinically Combination coronavirus disorder dose Efficacy FDA healthy Hospitalization IgG levels increased mortality Lymphocytes majority mRNA mRNA vaccination mRNA vaccine mRNA-1273 Multiple myeloma NAb NAbs Patient plasma plasma cell disorder. Prospective Study required responses SARS CoV-2 SARS-CoV-2 therapy Treatment vaccination vaccine dose [DOI] 10.1111/ejh.13826 PMC 바로가기
Cross-sectional study for COVID-19-related mortality predictors in a Brazilian state-wide landscape: the role of demographic factors, symptoms and comorbiditiesArticle Published on 2022-10-172022-11-15 Journal: BMJ Open [Category] 진단, [키워드] 95% CI Analysis association cardiac epidemiology Clinical severity Comorbidity COVID-19 COVID-19 pandemic criteria criterion cross-sectional study dataset death demographic characteristics Demographic factors diabete diabetes & diagnosed disease disorder Effects electronic medical record endocrinology Epidemiology evaluate Factor health system healthcare highlight hospitalisation hospitalised ICU implementation increased mortality information Intervention kidney kidney & Kidney disease majority measure mitigate Mortality multicollinearity non-hospitalised non-ICU non-ICU patient occurred Patient patients patients older predictor Prevent public health public health. reverse transcription-PCR secondary outcome selected severity Sex state suffered Symptom Urinary tract urinary tract disorders virus [DOI] 10.1136/bmjopen-2021-056801 PMC 바로가기
Incidence of COVID-19 and Identification of Possible Risk Factors Associated with COVID-19 in Acute Renal Transplant Recipients in PakistanArticle Published on 2022-10-042022-11-15 Journal: Annals of transplantation [Category] COVID19(2023년), SARS, 진단, [키워드] acquisition age baseline Characteristics Comorbidities Compliance COVID-19 COVID-19 disease Diabetes Mellitus enrolled Factor female gender Follow-up Gender Health status hospital Hospital stay identification identify immunosuppressive therapies incidence increased mortality Infection males management measure Measures overall mortality Patient patients Protective questionnaire raised recipient recipients renal required risk factor Risk factors SARS-COV-2 infection serum creatinine susceptible symptomatic Transplant transplants with COVID-19 [DOI] 10.12659/AOT.937688 PMC 바로가기
SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna® vaccinated patients on maintenance immunoapheresis – a cohort studyArticle Published on 2022-09-262022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] antibody Antibody Response Autoimmune disease average cohort study Control COVID-19 Effectiveness groups humoral immune response IgG IgG apheresis immune response Immunoadsorption Immunocompromised Immunoglobulin immunosuppressive drugs increased mortality independent LDL less Moderna morbidity mRNA-1273 outcome Patient patients populations Protein reduction SARS-CoV-2 IgG SARS-CoV-2 IgG spike (S) protein antibody SARS-CoV-2 pandemic secondary outcome Spike protein the median Treatment vaccination vaccination. [DOI] 10.3389/fimmu.2022.969193 PMC 바로가기
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trialRandomized Controlled Trial Published on 2022-09-052022-10-05 Journal: Critical Care [Category] 임상, [키워드] Acute kidney injury Adequate Adult patient antibiotic Antibiotics clinical Clinical decision support clinical trial control group COVID-19 pandemic Critically ill patient critically ill patients data-driven dose Efficacy eligible Endpoint EudraCT European evaluate faster feasibility feasible for inclusion ICU implementation IMPROVE incidence Inclusion increased mortality Infection intervention group Lactate Mortality Netherland not significantly different outcome patients personalised pharmacokinetic pharmacokinetics Primary outcome randomisation randomised Registered renal right Safe Sepsis Septic shock significantly Support Therapeutic Drug Monitoring Therapeutic drug monitoring. Trial was obtained [DOI] 10.1186/s13054-022-04098-7 PMC 바로가기 [Article Type] Randomized Controlled Trial
P156. Mortality of operative spinal fractures in COVID-19 positive patients using data from a national databaseConference abstract Published on 2022-09-012022-10-05 Journal: The Spine Journal [Category] 진단, [키워드] Abstract Acute kidney injury acute respiratory distress age AKI all-cause mortality Analysis Antigen ARDS baseline body mass index Care Clinical data Cohort cohort study collected data comparable complications control group COVID COVID-19 COVID-19 negative COVID-19 pandemic COVID-19 positive patient criteria Critical database diagnostic drugs event examined FDA Gender group Health include increase increased mortality increased risk individual information Intervention Lower management Mortality National Older operative outcome Patient patients PCR performed positive Primary outcome question raise Ratio required Research resource RT-PCR Sepsis Spinal cord injury subsequent surgical sustained syndrome tested total population upper Venous Thromboembolism VTE was collected women [DOI] 10.1016/j.spinee.2022.06.413 [Article Type] Conference abstract
Impact of obstructive sleep apnea on clinical outcomes in patients hospitalized with COVID-19Observational Study Published on 2022-09-012022-10-05 Journal: Sleep & breathing = Schlaf & Atmung [Category] 임상, [키워드] 95%CI addition age analyses association BMI Body cardiovascular disease clinical Clinical outcome cohort study collected Complete coronavirus COVID-19 COVID-19 disease COVID-19 infection COVID-19 patient diabetes diagnosed with COVID-19 disease Gender group hospital Hospital stay Impact incidence increased mortality increased risk independent index investigated Lung disease male mass mechanism medical record Mortality Non-COVID-19 not differ Obstructive obstructive sleep apnea OSA Patient patients hospitalized patients with COVID-19 Presence Prevalence risk factor risk factor. suggested was increased with COVID-19 [DOI] 10.1007/s11325-021-02476-z PMC 바로가기 [Article Type] Observational Study
Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency departmentArticle Published on 2022-09-012022-11-15 Journal: Internal and Emergency Medicine [Category] 바이오마커, [키워드] 95% CI 95% confidence interval adjusted hazard ratio ALT Analysis AST AUC cohort study coronavirus COVID-19 COVID-19 patient Cox regression cut-off Department disease Emergency Endpoint FIB-4 fibrosis Fibrosis-4 High-flow oxygen identify increased mortality index Liver damage Liver fibrosis. liver transaminase log-rank test mechanical ventilation Mortality mortality risk Patient performed predict Predictive Prognosis ROC analysis ROC Curve secondary to define were used worse prognosis [DOI] 10.1007/s11739-022-02997-9 PMC 바로가기
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients심각한 COVID-19-Epiphenomena에서 EBV 및 CMV의 재활성화 또는 치료가 필요한 Hyperinflammation의 트리거? 중환자의 대규모 사례 시리즈Article Published on 2022-09-012022-09-11 Journal: Journal of Intensive Care Medicine [Category] 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed ARDS Chain Reaction Characteristics Clinical deterioration CMV cohort study comparable connection control group coronavirus Corticosteroid Course COVID-19 Critically ill Critically ill patient critically ill patients cytomegalovirus decrease described Diagnosis disease EBV Epstein-Barr virus Follow-up analysis Ganciclovir high risk hyperinflammation ICU in viral incidence increased mortality initiation of treatment intensive care intensive care unit intensive care unit. majority Non-COVID-19 non-COVID-19 patient Non-COVID-19 patients outcome Patient polymerase chain polymerase chain reaction Reactivation remains uncertain retrospective rituximab SARS-CoV-2 screened Sepsis sepsis patient Sery severe acute respiratory syndrome Coronavirus severe COVID-19 single-center survived systemic corticosteroid treated Treatment Trigger Viral load viral reactivation virus virus with COVID-19 [DOI] 10.1177/08850666211053990 PMC 바로가기 [Article Type] Article
Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortalityResearch article Published on 2022-09-012022-10-05 Journal: Cytokine [Category] COVID19(2023년), SARS, 변종, [키워드] 25-hydroxyvitamin D acute respiratory syndrome adaptive amplification Analysis coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 mortality creatinine Critical cytoplasm dead dead patient erythrocyte sedimentation rate ESR evaluate Factors Genetic Genotype genotyped Host IFITM3 Impact increased mortality indicated innate immune response Interferon-induced transmembrane protein 3 liver enzymes membrane minor allele frequency Mortality multivariate logistic regression Mutation parameters Patient PCR polymorphism positive profiles required Result SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 significantly more suggested transmembrane protein uric acid viral cell [DOI] 10.1016/j.cyto.2022.155957 [Article Type] Research article